10/21/2025Sunnovo Invests in Byterna to Advance Circular mRNA

10/21/2025Kelun-Biotech's Sacituzumab Tirumotecan Shows Strong Phase 3 Results

10/20/2025Akeso Reports Strong China Data for Ivonescimab in Lung Cancer

10/20/2025Sanofi Launches €1B Insulin API Manufacturing Project in Beijing

10/20/2025CDE Seeks Comments on Implementation Recommendations and Chinese Tran...

10/20/2025CDE Seeks Feedbacks on Draft Technical and Submission Requirements for...

10/20/2025China Accelerates Nationwide Rollout of Real-Time BMI Fund Settlement

10/20/2025Kelun Gains China Approval for First Homegrown HER2 Breast Cancer ADC

10/17/2025I-Mab to Rebrand as NovaBridge Biosciences and Pursue Hong Kong IPO

10/17/2025RemeGen's Telitacicept Demonstrates Strong Phase 3 Efficacy in Lupus, ...

10/17/2025Recent Executive Moves

10/15/2025Pfizer CEO Calls for Greater U.S.–China Collaboration in Biopharma In...

10/15/2025Sino Biopharma's TQB2102 Receives Breakthru Therapeutic Designation in...

10/14/2025Multitude Reports Updated Safety and Dose Findings for AMT-116 at ESMO...

10/14/2025Biokin and SystImmune Present Promising Early Data for EGFR×HER3 Bisp...

10/13/2025Kelun-Biotech Wins China Approval for TROP2 ADC in EGFR-Mutant NSCLC A...

10/13/2025Micot Pharma Completes Over CNY 200M Series D Financing, Advances Towa...

10/13/2025Walgreens Boots Alliance Fully Exits Nanjing Pharma

10/13/2025Hope Medicine Reports Positive Global Phase 2 Results for HMI-115

10/13/2025China Introduces New Regulations to Govern Clinical Research and Appli...

10/13/2025Hansoh Pharma Reports Phase II Data for Oral B7H3 ADC HS-20093

10/13/2025Lepu Reports Early Clinical Data for ADC Programs in Various Cancers

10/13/2025U.S. Senate Approves Revised China Biotech Competition Bill with Softe...

10/13/2025First Drug Patent Term Extension Granted In China (Mondaq)

10/8/2025China Biopharma Financing Rebounds in September as IPO Pipeline Surges

10/8/2025License-Out Deals in China Drop Sharply in September Amid Steady Deal ...

10/8/2025Only Two Novel Drugs Win China Approval in September as Local Innovati...

10/3/2025Medilink Initiates U.S. Phase 1/2 Trial for VEGF-Targeted ADC YL242

10/3/2025Santen and RemeGen Files Chinese BLA for RC28-E

10/1/2025China Rolls Out 2025 Pharmacopoeia to Sharpen Drug Oversight

Page:4/372 Total number of articles:11144: [First][<<] [2] [3] [4] [5] [6] [>>] [End]